Skip to main content
23andMe Holding Co. (MEHCQ)
OTCMKTS · Delayed Price · Currency is USD
1.300
+0.030 (2.36%)
Apr 23, 2025, 4:00 PM EDT

23andMe Holding Co. Revenue

23andMe Holding Co. had revenue of $60.26M in the quarter ending December 31, 2024, with 34.67% growth. This brings the company's revenue in the last twelve months to $208.78M, down -15.81% year-over-year. In the fiscal year ending March 31, 2024, 23andMe Holding Co. had annual revenue of $219.64M, down -26.66%.

Revenue (ttm)
208.78M
Revenue Growth
-15.81%
P/S Ratio
0.16
Revenue / Employee
365.63K
Employees
582
Market Cap
34.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024219.64M-79.85M-26.66%
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

23andMe Holding Co. News

More News